Hydrochlorothiazide and the Risk of Malignant Melanoma - Reply

Anton Pottegård*, David Gaist

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalJAMA Internal Medicine
Volume178
Issue number10
Pages (from-to)1425-1426
ISSN2168-6106
DOIs
Publication statusPublished - 1. Oct 2018

Cite this

@article{ca7fa05b301d4410a9723fa2a9d23f1d,
title = "Hydrochlorothiazide and the Risk of Malignant Melanoma - Reply",
author = "Anton Potteg{\aa}rd and David Gaist",
year = "2018",
month = "10",
day = "1",
doi = "10.1001/jamainternmed.2018.4315",
language = "English",
volume = "178",
pages = "1425--1426",
journal = "Archives of Internal Medicine",
issn = "0003-9926",
publisher = "The JAMA Network",
number = "10",

}

Hydrochlorothiazide and the Risk of Malignant Melanoma - Reply. / Pottegård, Anton; Gaist, David.

In: JAMA Internal Medicine, Vol. 178, No. 10, 01.10.2018, p. 1425-1426.

Research output: Contribution to journalComment/debateResearchpeer-review

TY - JOUR

T1 - Hydrochlorothiazide and the Risk of Malignant Melanoma - Reply

AU - Pottegård, Anton

AU - Gaist, David

PY - 2018/10/1

Y1 - 2018/10/1

U2 - 10.1001/jamainternmed.2018.4315

DO - 10.1001/jamainternmed.2018.4315

M3 - Comment/debate

VL - 178

SP - 1425

EP - 1426

JO - Archives of Internal Medicine

JF - Archives of Internal Medicine

SN - 0003-9926

IS - 10

ER -